Compare Kenvue Inc. Common Stock (KVUE) vs Trip.com Group Ltd (TCOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kenvue Inc. Common Stock vs Trip.com Group Ltd — how do they compare? Kenvue Inc. Common Stock trades at $17.68 (market cap $34.06B), while Trip.com Group Ltd trades at $38.91 (market cap $23.75B). The key difference: Kenvue Inc. Common Stock is the larger of the two by market cap, and Kenvue Inc. Common Stock pays the higher dividend (4.74%). Which is the better fit depends on your goals.
| KVUE | TCOM | |
|---|---|---|
Market Cap | $34.06B | $23.75B |
Volume | 23,267,228 | 2,089,737 |
Sector | Consumer Staples | Consumer Cyclical |
52-Week High | $19.83 | $78.96 |
52-Week Low | $14.11 | $37.96 |
Enterprise Value | $41.56B | $15.91B |
Dividend Yield | 4.74% | 0.42% |
Typical Hold Time | — | 79 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Trip.com (TCOM) trades at $38.90, up 2.13% with bearish technical signals despite strong fundamentals. The company reported Q2 2026 EPS of $1.07, beating expectations, with revenue growth of 6% year-over-year. Valuation metrics appear attractive with P/E of 7.34 and P/S of 2.6, while maintaining robust profitability with 36.9% net income margin and 15.74% ROE.
Despite regulatory headwinds from recent antitrust penalties, Trip.com's international expansion and strong cash flow generation support long-term growth. The stock faces near-term technical pressure but offers fundamental value with 45.6% upside to the $56.64 consensus price target. Key risks include regulatory scrutiny and competitive pressures in the travel sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kenvue Inc. Common Stock
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →About Trip.com Group Ltd
Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 78% of sales from accommodation reservations and transportation ticketing in 2020. The rest of revenue comes from package tours and corporate travel. Prior to the pandemic in 2019, the company generated 25% of revenue from international business, which is important to its margin expansion. Most of sales come from websites and mobile platforms, while the rest come from call centers. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Toncheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.
Read more on TCOM →
